U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H14N2O2
Molecular Weight 254.2839
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NEPAFENAC

SMILES

NC(=O)CC1=C(N)C(=CC=C1)C(=O)C2=CC=CC=C2

InChI

InChIKey=QEFAQIPZVLVERP-UHFFFAOYSA-N
InChI=1S/C15H14N2O2/c16-13(18)9-11-7-4-8-12(14(11)17)15(19)10-5-2-1-3-6-10/h1-8H,9,17H2,(H2,16,18)

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
NEPAFENAC
EMA EPAR   INN   JAN   MART.   MI   ORANGE BOOK   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
nepafenac [INN]
Common Name English
Nepafenac [WHO-DD]
Common Name English
NEPAFENAC [USAN]
Common Name English
NEPAFENAC [EMA EPAR]
Common Name English
2-(2-Amino-3-benzoylphenyl)acetamide
Systematic Name English
NEVANAC
Brand Name English
NEPAFENAC [MART.]
Common Name English
AL-6515
Code English
NEPAFENAC [ORANGE BOOK]
Common Name English
2-AMINO-3-BENZOYLBENZENEACETAMIDE
Systematic Name English
NEPAFENAC [USP-RS]
Common Name English
NEPAFENAC [MI]
Common Name English
NEPAFENAC [VANDF]
Common Name English
NEPAFENAC [JAN]
Common Name English
AHR-9434
Code English
Classification Tree Code System Code
NDF-RT N0000000160
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
NDF-RT N0000175721
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
NDF-RT N0000175722
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
NCI_THESAURUS C257
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
WHO-VATC QS01BC10
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
EMA ASSESSMENT REPORTS NEVANAC (AUTHORIZED: PAIN, POSTOPERATIVE)
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
WHO-ATC S01BC10
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
EMA ASSESSMENT REPORTS NEVANAC (AUTHORIZED: OPTHALMOLOGIC SURGICAL PROCEDURES)
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
Code System Code Type Description
MESH
C414203
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
PUBCHEM
151075
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
LACTMED
Nepafenac
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
CHEBI
75922
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
INN
7685
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
SMS_ID
100000085451
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
WIKIPEDIA
Nepafenac
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
DRUG BANK
DB06802
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
NCI_THESAURUS
C66228
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
RXCUI
298665
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY RxNorm
EPA CompTox
DTXSID0048638
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
RS_ITEM_NUM
1460317
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
EVMPD
SUB09197MIG
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
DAILYMED
0J9L7J6V8C
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
DRUG CENTRAL
1899
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
ChEMBL
CHEMBL1021
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
FDA UNII
0J9L7J6V8C
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
MERCK INDEX
m7823
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY Merck Index
IUPHAR
7564
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
CAS
78281-72-8
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
USAN
II-86
Created by admin on Fri Dec 15 15:45:15 UTC 2023 , Edited by admin on Fri Dec 15 15:45:15 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of AMFENAC
SUBSTANCE RECORD
Structure of NEPAFENAC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966